ShEEP-IC: Jess Simple Western System
SheEEP-IC:Jess 简单西方系统
基本信息
- 批准号:10176059
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-10-01 至 2021-09-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAntibodiesApolipoproteinsAreaBehavioralBiologicalBiological AssayBiology of AgingBlood VesselsBlood capillariesCancer BiologyCapillary ElectrophoresisCardiovascular systemCell Culture SystemCellsComputersDataDetectionExposure toFluorescenceFundingGelGenomicsHealthHourHypoxia Inducible FactorImageImmunoblottingImpaired cognitionKnowledgeLabelLaboratoriesLinkMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateManufacturer NameMedicalMembraneMental DepressionMental HealthMethodsMinorModelingMusPathway interactionsProductivityProteinsQuality of lifeReproducibilityRequest for ApplicationsResearchResearch PersonnelRunningSamplingSheepSignal PathwaySignal TransductionSiteSpeedSpinal cord injuryStressSystemTechniquesTechnologyTissuesTrainingTraumatic Brain InjuryTubeVeteransWestern Blottingdrug candidateexperimental studyfunctional electrical stimulationfunctional outcomesgel electrophoresisgenetic manipulationhuman subjectimprovedinstrumentlink proteinnew technologynovel therapeuticsweb site
项目摘要
This application requests funds to purchase a Protein Simple Jess automated capillary
electrophoresis and western blotting system. This instrument performs separation of proteins
by capillary electrophoresis followed by in-gel immunoblotting with chemiluminescent or
fluorescent detection of immunolabeled bands. Normalization using in-gel fluorescent labeling
of all proteins is also available. The user loads samples and primary and secondary antibodies
into a multiwell plate. All other steps from protein loading to protein separation,
immunodetection and image acquisition are done automatically. Specific advantages of this
technology include the ability to obtain western blotting and normalization data for 24 samples
in under 4 hours, elimination of the variability inherent in electro-transfer of protein from the
electrophoresis gel to immunoblotting membranes, and very high sensitivity (less than 1.5
micrograms protein is required per lane). As a result, inter-assay variability approaches 15% and
throughput is increased. This technology is thus well suited to experiments requiring that large
numbers of samples and/or antibodies be run. A growing number of antibodies have been
validated in this system, with over 1,400 currently listed on the manufacturer’s website. The
instrument will facilitate research in several areas. In spinal cord injury research, it will be used
for ongoing analysis of changes in intracellular signaling elicited by functional electrical
stimulation in ongoing research in both mice and human subjects, and to elucidate mechanisms
for changes in functional outcomes observed with genetic manipulation or candidate drugs. In
traumatic brain injury research, this technology will be invaluable in investigating a growing
number of proteins linked to vascular and behavioral abnormalities following repeated
exposures to mild blast waves. In ongoing Alzheimer’s disease research, protein levels of key
factors identified through an ever-growing range of genomics techniques aimed at
understanding the biological basis for the strong link between apolipoprotein epsilon 4 and
cognitive impairment will be interrogated. New research investigating new drug candidates to
mitigate effects of depression is also expected to rely heavily on the capabilities of this systems.
Among minor users, the instrument will be used to accelerate progress on research on multiple
aspects of cancer biology in cell culture systems that relies continuously on western blotting for
a wide variety of endpoints and, in cardiovascular research, to enhance research that focuses
on intracellular stress signaling pathways converging on hypoxia-inducible factors which utilizes
western blotting to characterize activation states of such pathways by western blotting.
该申请要求资金购买 Protein Simple Jess 自动毛细管
电泳和蛋白质印迹系统该仪器进行蛋白质分离。
通过毛细管电泳,然后使用化学发光或凝胶内免疫印迹法
使用凝胶内荧光标记对免疫标记条带进行荧光检测。
用户还可以加载所有蛋白质的样品以及一抗和二抗。
从蛋白质加载到蛋白质分离的所有其他步骤,
免疫检测和图像采集是自动完成的。
技术包括获得 24 个样本的蛋白质印迹和标准化数据的能力
在 4 小时内,消除了蛋白质电转移固有的变异性
电泳凝胶到免疫印迹膜,灵敏度非常高(小于1.5
每个泳道需要微克蛋白质)因此,测定间变异性接近 15%,并且
因此,该技术非常适合需要如此大的实验。
需要检测的样品和/或抗体数量不断增加。
在此系统中进行了验证,目前制造商网站上列出了 1,400 多个。
仪器将促进多个领域的研究,它将用于脊髓损伤研究。
用于持续分析功能性电引起的细胞内信号传导变化
刺激正在进行的小鼠和人类受试者研究,并阐明机制
用于通过基因操作或候选药物观察到的功能结果的变化。
创伤性脑损伤研究中,这项技术对于研究不断增长的
重复后与血管和行为异常相关的蛋白质数量
在正在进行的阿尔茨海默病研究中,蛋白质水平是关键。
通过不断增长的基因组学技术确定的因素
了解载脂蛋白 epsilon 4 和载脂蛋白 epsilon 之间紧密联系的生物学基础
认知障碍的新研究将调查新候选药物。
缓解抑郁症的效果预计也将在很大程度上依赖于该系统的功能。
在未成年用户中,该仪器将用于加速多项研究的进展
细胞培养系统中癌症生物学的各个方面,持续依赖于蛋白质印迹法
各种各样的终点,并且在心血管研究中,加强以下方面的研究:
细胞内应激信号通路汇聚于缺氧诱导因子,利用
通过蛋白质印迹来表征此类途径的激活状态。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHER P CARDOZO其他文献
CHRISTOPHER P CARDOZO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHER P CARDOZO', 18)}}的其他基金
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Romosozumab 可改善慢性 SCI 患者的骨矿物质密度和结构
- 批准号:
10418624 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Romosozumab 可改善慢性 SCI 患者的骨矿物质密度和结构
- 批准号:
10664874 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Romosozumab 可改善慢性 SCI 患者的骨矿物质密度和结构
- 批准号:
10664874 - 财政年份:2020
- 资助金额:
-- - 项目类别:
ShEEP Request for A Metabolic and Behavioral Phenotyping System
ShEEP 请求建立代谢和行为表型系统
- 批准号:
9795306 - 财政年份:2019
- 资助金额:
-- - 项目类别:
[ShEEP/LAMb] Request for a Seahorse Extracellular Flux Analyzer
[ShEEP/LAMb] 索取 Seahorse 细胞外通量分析仪
- 批准号:
9209599 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Notch and Wnt signaling in protection by nandrolone against disuse atrophy
Notch 和 Wnt 信号传导在诺龙防止废用性萎缩中的保护作用
- 批准号:
8202501 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Notch and Wnt signaling in protection by nandrolone against disuse atrophy
Notch 和 Wnt 信号传导在诺龙防止废用性萎缩中的保护作用
- 批准号:
8840070 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Notch and Wnt signaling in protection by nandrolone against disuse atrophy
Notch 和 Wnt 信号传导在诺龙防止废用性萎缩中的保护作用
- 批准号:
8424827 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Attenuation of denervation atrophy by nandrolone: molecular mechanisms
诺龙减轻去神经萎缩:分子机制
- 批准号:
7750432 - 财政年份:2009
- 资助金额:
-- - 项目类别:
相似国自然基金
缺氧通过HIF1α/TXNDC5通路调控IgG4相关性疾病B细胞分化及抗体类别转换重组
- 批准号:82302028
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
I型干扰素通路在抗MDA5抗体阳性皮肌炎相关间质性肺疾病中的作用和机制研究
- 批准号:82302020
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
神经胶质细胞抗体相关疾病对利妥昔单抗反应的差异性及其机制探究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
吲哚丙烯酸对MOG抗体相关疾病小胶质细胞激活和神经炎症的调控及临床意义
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
靶向gp350/CD89的双特异抗体对EB病毒感染及EBV相关淋巴增殖性疾病的免疫治疗研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Potential of tissue kallikreins as therapeutic targets for neuropsychiatric lupus
组织激肽释放酶作为神经精神狼疮治疗靶点的潜力
- 批准号:
10667764 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The role of alpha-synuclein in nucleolar DNA double-strand break repair and cellular senescence
α-突触核蛋白在核仁 DNA 双链断裂修复和细胞衰老中的作用
- 批准号:
10677497 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Identifying and understanding the role of repeat RNAs and RAN proteins in Alzheimer's disease
识别和理解重复 RNA 和 RAN 蛋白在阿尔茨海默病中的作用
- 批准号:
10833734 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Combining electron and nuclear magnetic resonance to track Alzheimer's amyloid-beta oligomer-to-fibril conversion
结合电子和核磁共振来追踪阿尔茨海默病β淀粉样蛋白寡聚物到原纤维的转化
- 批准号:
10662904 - 财政年份:2023
- 资助金额:
-- - 项目类别: